Correction to: Neurexin 3 transmembrane and soluble isoform expression and splicing haplotype are associated with neuron inflammasome and Alzheimer's disease

Akitoyo Hishimoto; Olga Pletnikova; Doyle Lu Lang; Juan C Troncoso; Josephine M Egan; Qing-Rong Liu

doi:10.1186/s13195-019-0493-0

Correction to: Neurexin 3 transmembrane and soluble isoform expression and splicing haplotype are associated with neuron inflammasome and Alzheimer's disease

Alzheimers Res Ther. 2019 May 7;11(1):39. doi: 10.1186/s13195-019-0493-0.

Authors

Akitoyo Hishimoto¹, Olga Pletnikova², Doyle Lu Lang³, Juan C Troncoso², Josephine M Egan³, Qing-Rong Liu⁴

Affiliations

¹ Department of Psychiatry, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-Cho, Chuo-Ku, Kobe, 650-0017, Japan.
² Departments of Pathology, Neuropathology Division, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD, 21205, USA.
³ Lab of Clinical Investigation, NIA-NIH, 251 Bayview Blvd, Baltimore, MD, 21224, USA.
⁴ Lab of Clinical Investigation, NIA-NIH, 251 Bayview Blvd, Baltimore, MD, 21224, USA. [email protected].

Abstract

Following publication of the original article [1], the authors reported that Fig. 6 contains a mistake. The Fig. 6F is a duplicate of Fig. 6E of Braak 5.

Publication types

Published Erratum